Tharimmune, Inc. — Director's Dealing 2022

Jul 18, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hillstream BioPharma Inc. (HILS)
CIK: 0001861657
Period of Report: 2022-07-14

Reporting Person: Appajosyula Sireesh (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-14	Common Stock	G	75757	—	Disposed	0	Indirect
2022-07-14	Common Stock	G	7576	—	Acquired	7576	Indirect

Footnotes

F1: The shares of common stock were owned by Mercer Lake Group LLC. Sireesh Appajosyula is the Managing Member of Mercer Lake Group LLC and in such capacity had the right to vote and dispose of the securities held by such entity.

F2: The shares of common stock are owned by Channel BioConsulting, LLC. Sireesh Appajosyula is the Managing Member of Channel BioConsulting, LLC and in such capacity has the right to vote and dispose of the securities held by such entity.